Search Results - "Woermann, Sonja M."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Abstract PR-15: Identifying synergistic combinations with KRAS inhibition in PDAC by Thege, Fredrik I, Hoskins, Amber, Woermann, Sonja M, Maitra, Anirban

    Published in Cancer research (Chicago, Ill.) (15-09-2024)
    “…Abstract Background: To date, targeted therapies have largely failed in eliciting sustained responses in advanced pancreatic ductal adenocarcinoma (PDAC)…”
    Get full text
    Journal Article
  5. 5

    Abstract C057: Delineating tissue-specific oncogene selection with autochthonous CRISPR activation screening by Thege, Fredrik I., Woermann, Sonja M., Maitra, Anirban

    Published in Cancer research (Chicago, Ill.) (16-01-2024)
    “…Abstract Background: While the genetic landscapes of pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC) are well described, the…”
    Get full text
    Journal Article
  6. 6

    Abstract C55: Mapping the pharmacotranscriptomic landscape of pancreatic circulating tumor cell organoids by Thege, Fredrik I., Barathi, Bhargavi B., Rupani, Dhwani N., Woermann, Sonja M., Rhim, Andrew D.

    Published in Cancer research (Chicago, Ill.) (15-12-2019)
    “…Abstract Introduction: Pancreatic cancer is characterized by early metastasis and resistance to chemotherapy. To elucidate the transcriptional reprogramming…”
    Get full text
    Journal Article
  7. 7

    Abstract 3: In vivo CRISPR activation screening identifies tissue-specific oncogene selection by Thege, Fredrik Ivar, Woermann, Sonja M., Maitra, Anirban

    Published in Cancer research (Chicago, Ill.) (04-04-2023)
    “…Abstract Background: While the genetic landscapes of pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC) are relatively well…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Abstract C049: Loss of RNF43 creates an OXPHOS dependency in early pancreatic neoplasia by Sagara, Akiko, Chen, Brandon, Yee, Nathaniel G., Siemann, Megan J., Lyssiotis, Costas A., Shah, Yatrik M., Woermann, Sonja M., Maitra, Anirban

    Published in Cancer research (Chicago, Ill.) (16-01-2024)
    “…Abstract Pancreatic ductal adenocarcinoma (PDAC) has a dismal 5-year survival of 12%. RNF43 is frequently mutated in pancreatic cystic neoplasms, including…”
    Get full text
    Journal Article
  11. 11

    Abstract PR-18: RNF43 Loss Induces an IRE1-dependent Metabolic Reprogramming in Pancreatic Cystic Neoplasms by Sagara, Akiko, Lv, Xiangdong, Chen, Brandon, Makino, Yuki, So, Shui Ping, Woermann, Sonja M, Lyssiotis, Costas A, Shah, Yatrik M, Ghosh, Bidyut, Chen, Xi, Fahrmann, Johannes F, Maitra, Anirban

    Published in Cancer research (Chicago, Ill.) (15-09-2024)
    “…Abstract Background: RNF43 is frequently mutated in intraductal papillary mucinous neoplasms (IPMNs), which are cystic precursor lesions of pancreatic ductal…”
    Get full text
    Journal Article
  12. 12

    Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts by Ruess, Dietrich A., Görgülü, Kivanc, Wörmann, Sonja M., Algül, Hana

    Published in Drugs & aging (01-05-2017)
    “…Pancreatic ductal adenocarcinoma is a devastating malignancy, which is the result of late diagnosis, aggressive disease, and a lack of effective treatment…”
    Get full text
    Journal Article